Literature DB >> 1596287

Transport and metabolism of cyclosporine in isolated rat hepatocytes. The effects of lipids.

T Prueksaritanont1, M Koike, B A Hoener, L Z Benet.   

Abstract

The effects of lipids on the uptake and metabolism of cyclosporine (CyA) were investigated in isolated rat hepatocytes. In the absence of lipids, CyA was rapidly taken up (reaching apparent steady state within 5 min) and highly associated with the cells (more than 80%). The CyA uptake was concentration independent over the concentration range studied (0.6 to 11.2 micrograms/mL). Metabolism, however, was relatively slow and saturable. Except for cholesterol (at concentrations up to 15.5 mM), all lipids tested [oleic acid; low density lipoproteins (LDL); and high density lipoproteins (HDL)] reduced CyA cell uptake as well as its metabolism in a concentration-dependent manner. The effects of LDL were much more pronounced when compared to those of HDL and oleic acid. At an LDL concentration of 1 microM, drug uptake, indicated by the cell-associated concentration at steady state, was about 49% of the control value, while CyA metabolism was inhibited completely. Drug uptake of about 82 and 91% and CyA disappearance of 75 and 68% of the relevant control values were observed with HDL and oleic acid at concentrations of 10 microM and 0.7 mM, respectively. Apparently, lipids decreased CyA metabolism by reducing the concentration of CyA available for transport into the cells. These findings further support the suggestion of an important role for plasma lipids in the disposition of CyA.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1596287     DOI: 10.1016/0006-2952(92)90643-w

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  4 in total

Review 1.  Distribution of cyclosporin in organ transplant recipients.

Authors:  Fatemeh Akhlaghi; Andrew K Trull
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

2.  Liposomal formulations of cyclosporin A: influence of lipid type and dose on pharmacokinetics.

Authors:  A Fahr; M Holz; G Fricker
Journal:  Pharm Res       Date:  1995-08       Impact factor: 4.200

3.  HPLC assay for FK 506 and two metabolites in isolated rat hepatocytes and rat liver microsomes.

Authors:  B Y Perotti; T Prueksaritanont; L Z Benet
Journal:  Pharm Res       Date:  1994-06       Impact factor: 4.200

4.  Epigenetic and antitumor effects of platinum(IV)-octanoato conjugates.

Authors:  Vojtech Novohradsky; Ilaria Zanellato; Cristina Marzano; Jitka Pracharova; Jana Kasparkova; Dan Gibson; Valentina Gandin; Domenico Osella; Viktor Brabec
Journal:  Sci Rep       Date:  2017-06-16       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.